maritide glp-1 How Does Work? How does MariTide Work?

Food and Drug Administration (FDA) approved Mounjaro (tirzepatide) injection, Eli Lilly and Company's (NYSE: LLY) new once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes

GLP-1 medications are FDA-approved for type 2 diabetes management and, at higher doses, for chronic weight management in adults with obesity or overweight with weight-related comorbidities

This natural response is one of the reasons plateaus often occur during long-term GLP-1 treatment

These findings suggest that dose optimization may significantly enhance treatment outcomes across the GLP-1 class ^1

Be well - Naturally